Rikke Noergaard Pedersen

MD, PhD. Clinical Epidemiology. Main research area: Late breast cancer recurrence- risk, prognosis and prevention.

[Department of Clinical Epidemiology, Aarhus @DCEAarhus]

New research first-authored by @NoergaardRikke with co-authors @boztdk, Lene Mellemkjær, @ChristiansenPe8, Bent Ejlertsen, Timothy Lee Lash, @NoergaardM, and @DeeCroninFenton.

@AUHdk @AarhusUni_int

[Journal of Clinical Oncology @JCO_ASCO]

👩‍👩‍👧 Population-based #BreastCancer cohort investigates impact of late recurrence (≥10 years post-diagnosis) on mortality, prognosis & survival.
🌟Late recurrence less aggressive, associated w/ better prognosis compared to early. https://t.co/ZqPAItJLFS #BCSM @NoergaardRikke

[Rikke Noergaard Pedersen @NoergaardRikke]

Our paper ”Mortality After Late Breast Cancer Recurrence in Denmark” featured as companion article in JCO Oncology Grand Rounds.

A very important topic! @JCO_ASCO

👉https://t.co/bCGI9BKGjN

@DeeCroninFenton @NoergaardM @cancer_dk @AarhusUni @DCEAarhus @breastcancer

[Rikke Noergaard Pedersen @NoergaardRikke]

@larsfolkestad @JCO_ASCO We followed the patients from 6 months after the date of recurrence.

[Rikke Noergaard Pedersen @NoergaardRikke]

How is the prognosis after late breast cancer(BC) recurrence?
Do patients who develop late recurrence have a better prognosis than patients with earlier recurrence?

Check our paper “Mortality After Late Breast Cancer Recurrence in Denmark”
@JCO_ASCO
👉https://t.co/miheUSyhSP

[Rikke Noergaard Pedersen @NoergaardRikke]

Thank you to co-authors @DeeCroninFenton @NoergaardM Lene Mellemkjær and Bent Ejlertsen. Furthermore @cancer_DK and @AarhusUni for funding.

@DCEAarhus @breastcancer @BreastSurvival

[Rikke Noergaard Pedersen @NoergaardRikke]

Overall, women who developed late recurrence had better prognosis compared with those with early recurrence with lower hazards of BC-specific mortality, lower cumulative BC-specific mortality, lower BC-specific MRs, and longer survival time.